Next week, Torrent Pharmaceuticals is set to launch a hefty debt sale, targeting around ₹12,500 crore in fundraising. This capital will play a critical role in facilitating the company’s acquisition of JB Chemicals & Pharmaceuticals. The strategy includes issuing commercial paper and non-convertible debentures, showcasing the increasing reliance on debt markets for corporate buyouts.